These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Olivares M; Neef A; Castillejo G; Palma GD; Varea V; Capilla A; Palau F; Nova E; Marcos A; Polanco I; Ribes-Koninckx C; Ortigosa L; Izquierdo L; Sanz Y Gut; 2015 Mar; 64(3):406-17. PubMed ID: 24939571 [TBL] [Abstract][Full Text] [Related]
4. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both. Dezsofi A; Szebeni B; Hermann CS; Kapitány A; Veres G; Sipka S; Körner A; Madácsy L; Korponay-Szabó I; Rajczy K; Arató A J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):283-7. PubMed ID: 18728522 [TBL] [Abstract][Full Text] [Related]
5. Nod2 is essential for temporal development of intestinal microbial communities. Rehman A; Sina C; Gavrilova O; Häsler R; Ott S; Baines JF; Schreiber S; Rosenstiel P Gut; 2011 Oct; 60(10):1354-62. PubMed ID: 21421666 [TBL] [Abstract][Full Text] [Related]
6. Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease. Cucchiara S; Stronati L; Aloi M J Clin Gastroenterol; 2012 Oct; 46 Suppl():S64-6. PubMed ID: 22955361 [TBL] [Abstract][Full Text] [Related]
7. Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. Kalliomäki M; Satokari R; Lähteenoja H; Vähämiko S; Grönlund J; Routi T; Salminen S J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):727-32. PubMed ID: 22134550 [TBL] [Abstract][Full Text] [Related]
8. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis. Agius LM J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386 [TBL] [Abstract][Full Text] [Related]
9. The microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain. Shanahan F Nutr Rev; 2012 Aug; 70 Suppl 1():S31-7. PubMed ID: 22861805 [TBL] [Abstract][Full Text] [Related]
10. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Verdu EF; Huang X; Natividad J; Lu J; Blennerhassett PA; David CS; McKay DM; Murray JA Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G217-25. PubMed ID: 18006603 [TBL] [Abstract][Full Text] [Related]
18. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease. Hirata Y; Ihara S; Koike K Pharmacol Res; 2016 Nov; 113(Pt A):574-584. PubMed ID: 27702681 [TBL] [Abstract][Full Text] [Related]
19. The importance of gut microbiota in mediating the effect of NOD2 defects in inflammatory bowel disease. Rogler G Gut; 2010 Feb; 59(2):153-4. PubMed ID: 20176638 [No Abstract] [Full Text] [Related]
20. Host genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiota. Smith P; Siddharth J; Pearson R; Holway N; Shaxted M; Butler M; Clark N; Jamontt J; Watson RP; Sanmugalingam D; Parkinson SJ PLoS One; 2012; 7(1):e30273. PubMed ID: 22272321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]